gabexate has been researched along with Acute Kidney Injury in 3 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of gabexate mesilate (FOY), a synthetic serine proteinase inhibitor, was compared with that of heparin in preventing the acceleration of bleeding after hemodialysis." | 7.67 | Hemodialysis using gabexate mesilate (FOY) in patients with a high bleeding risk. ( Okada, T; Shimada, Y; Tachimori, Y; Taenaka, N; Takahashi, H; Takezawa, J; Terada, N; Yoshiya, I, 1986) |
| "The efficacy of gabexate mesilate (FOY), a synthetic serine proteinase inhibitor, was compared with that of heparin in preventing the acceleration of bleeding after hemodialysis." | 3.67 | Hemodialysis using gabexate mesilate (FOY) in patients with a high bleeding risk. ( Okada, T; Shimada, Y; Tachimori, Y; Taenaka, N; Takahashi, H; Takezawa, J; Terada, N; Yoshiya, I, 1986) |
| "Pyogenic osteomyelitis is often accompanied by diabetes, but the disease in the clavicula has rarely been reported." | 1.30 | Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus. ( Kasamatsu, Y; Kondo, M; Nagata, H; Nakamura, Y; Yokoo, S; Yoshida, T; Yoshioka, K, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshioka, K | 1 |
| Nagata, H | 1 |
| Nakamura, Y | 1 |
| Kasamatsu, Y | 1 |
| Yokoo, S | 1 |
| Yoshida, T | 1 |
| Kondo, M | 1 |
| Sasaki, S | 1 |
| Taenaka, N | 1 |
| Terada, N | 1 |
| Takahashi, H | 1 |
| Tachimori, Y | 1 |
| Okada, T | 1 |
| Takezawa, J | 1 |
| Shimada, Y | 1 |
| Yoshiya, I | 1 |
3 other studies available for gabexate and Acute Kidney Injury
| Article | Year |
|---|---|
Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Clavicle; Diabetes Mellitus, Type 2; Dis | 1997 |
[Experimental study on renal protection against damage in kidneys subjected warm ischemia--protective effect of FOY, SOD, and PEG-SOD on ischemic acute renal failure].
Topics: Acute Kidney Injury; Animals; Gabexate; Guanidines; Ischemia; Kidney; Kidney Tubules; Necrosis; Poly | 1989 |
Hemodialysis using gabexate mesilate (FOY) in patients with a high bleeding risk.
Topics: Acute Kidney Injury; Adult; Aged; Anticoagulants; Blood Transfusion; Blood Volume; Drug Evaluation; | 1986 |